Neo-adjuvant and adjuvant therapy for skin melanoma

The problem of neo-adjuvant and adjuvant therapy for skin melanoma remains very high, because even after radical treatment, there is still a high probability of relapse or progression of the disease, especially for patients with a high risk of progression. The clinical relevance is determined not only by the increasing number of effective schemes, but also by the need to choose between preoperative and postoperative strategies, the duration of therapy, balancing between effectiveness, risk of toxicity, preserving the quality of life of patients. The topic of neo-adjuvant and adjuvant therapy for skin melanoma is currently at the center of clinical guidelines and research, and its importance continues to grow